In the subgroup analysis, Asian studies demonstrated a marked reduction in mortality (OR 0.15; 95% CI 0.08–0.28), while the European studies showed a trend toward increased mortality (OR 1.89; 95% CI 0.90–3.98).
← all excerpts
Emerging therapeutic regimens as alternatives to glucocorticoids for severe alcohol-associated hepatitis: a comprehensive review.
1
—
—